Sun, Gang
Zeng, Jia-Qi
Wu, Jun-Ling
Wang, Shu-Fang
Peng, Li-Hua
Yan, Bin
Pan, Fei
Li, Yi
Zhou, Guan-Zhou
Chen, Xiao-Dong
Wang, Zi-Kai
Wang, Xiang-Dong
Lian, Wan-Yuan
Yang, Yun-Sheng
Funding for this research was provided by:
the Twelfth Five-year Key Project (WS13C027)
the Extended Trial Project of Medical and Health Achievements (19WKS10)
the Major Science and Technology Program of Hainan Province (ZDKJ2019012)
the Clinical Research Supporting Fund of Chinese PLA General Hospital (2018FC-WJFWZX-2-15)
Special health care project of logistics scientific research project (23BJZ03)
The cultivation project for top talents in academic disciplines of the High-Level Scientific and Technological Innovation Talents Program (LZ202410)
National Natural Science Foundation of China (32170898)
Research on Health Beneficial Bacteria and Metabolites to Enhance Military Operational Capability (GCCRC-2024-002)
innovation Laboratory of Terahertz Biophysics (23-163-00-GZ-001-001-02-03)
Article History
Received: 19 December 2024
Accepted: 22 August 2025
First Online: 15 September 2025
Declarations
:
: This study involves human participants and was approved by the Ethics Committee of Chinese PLA General Hospital (S2019-292–02, S2023-007–01). Participants gave informed consent to participate in the study before taking part. This study has been registered in the Chinese Clinical Trial Registry (ChiCTR2000038516, registered September 23, 2020, ; ChiCTR2300069260, registered March 10, 2023, ).
: Not applicable.
: The authors declare that they have no competing interests.